For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

The company behind the drug donanemab said it will ask regulators to reconsider the decision. View on euronews ...

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...

A study examining the long-term effects of anti-amyloid therapy gantenerumab suggests that full amyloid plaque removal may help reduce Alzheimer’s symptoms in individuals at risk for dominantly ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

But new data from a recent clinical trial suggests that a previously discontinued experimental drug, called gantenerumab, ...